Key result
The AUC method demonstrated linearity for Olaparib, Pazopanib, and Abiraterone acetate at specific ppm ranges, enabling robust quantification of multiple anticancer drugs.
Population
Anticancer drugs in bulk dosage form (Olaparib, Pazopanib, Abiraterone acetate)
Design
Analytical method development and validation study
Answers are grounded in this paper and cite their sources.
May aid anticancer drug quality control; leaves open clinical translation and cardiovascular relevance.
The present research work outlines the development of simple, rapid, specific, precise and accurate UV spectroscopy where the area under the curve (AUC) method was employed to estimate anticancer drugs in their bulk dosage form. A wavelength range of 200–400 nm was selected for the analysis, with methanol used as the solvent throughout the study. We established robust protocols for the simultaneous quantification of multiple anticancer agents. Linearity was observed for Olaparib (OLA), Pazopanib (PAZO) and Abiraterone acetate (ABI) in a range of 2-10ppm, 1-5ppm and 12-20ppm respectively. The methods were optimized and validated with respect to various parameters and were validated according to International Council for Harmonization (ICH) guidelines(Q2R2) Where this method can be successfully applied for routine Quality Analysis.
No takes yet. Share an insight, caveat, or question.
Jani et al. (2026) studied this question. The AUC method demonstrated linearity for Olaparib, Pazopanib, and Abiraterone acetate at specific ppm ranges, enabling robust quantification of multiple anticancer drugs.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: